Immuno-Diagnostics Antibodies & Antigens for Veterinary NCDs (noncommunicable diseases) Test
Immuno-diagnostic antibodies and antigens for veterinary NCDs tests target markers associated with chronic conditions such as diabetes, cancer, and heart disease in animals. These tools enable precise detection and monitoring of noncommunicable diseases, facilitating early intervention, improved management strategies, and enhancing the quality of life for affected animals.
Important animals listed
Canine (dog)
Details
· Acute inflammation, infections
· Inflammatory diseases, infections
· Bacterial infections, sepsis
· Heart failure, cardiac disease
· Thrombosis, disseminated intravascular coagulation (DIC)
· Myocardial injury, heart disease
· Pancreatitis
Feline (cat)
Details
· Acute inflammation, infections
· Inflammatory diseases, infections
· Bacterial infections, sepsis
· Heart failure, cardiac disease
· Thrombosis, disseminated intravascular coagulation (DIC)
· Myocardial injury, heart disease
· Pancreatitis
Equine (horse)Details
· Acute inflammation, infections
· Thrombosis, disseminated intravascular coagulation (DIC)
· Myocardial injury, heart disease
Important NCDs listed
Other Chronic Diseases & Conditions, especially Noncommunicable Diseases (NCDs) such as inflammation, pancreatitis, kidney function impairment, coagulation disorders, cardiovascular diseases, and bone metabolism issues, including osteoporosis are other major health challenges affecting Animals. They greatly impact on animals’ health, lifespan, and comfort that is why are important to control environmental conditions. For instance, chronic inflammation raises the risk of numerous other diseases, pancreatitis impairs the digestion of foods, and kidney injury leads to toxins buildup.
The examples of coagulation problems include bleeding or clumsy clotting, cardiovascular diseases affect heart and circulation, and bone metabolism have an impact on the skeletons and movement. It is pertinent to highlight that these diseases are crucial for the effective care and welfare of domestic animals and more importantly pets who are valued as part of the family.
This is an area where both the pet owners as well as veterinarians should focus on in trying to understand the correlation of biomarkers to enable an accurate diagnosis that leads to correct care and treatment for the disease. The use of these biomarkers for regular health checkups can highly useful in the overall management of these chronic diseases and to improve the quality of life of these animals.
Validation data of GeneMedi's products
- Canine CRP
- Feline/Canine/Equine SAA
- Canine NT-proBNP
- Feline cTnI
GeneMedi's anti-cCRP monoclonal antibodies achieve excellent performance in immunoassays.
GeneMedi's monoclonal antibodies targeting cCRP (canine C-reactive protein) deliver outstanding performance across different immunoassay systems, ensuring high sensitivity and reliability for accurate cCRP detection. These antibodies are designed to support consistent and precise results, making them ideal for various diagnostic and research applications.
Figure 1. GeneMedi’s GMP-CAN-CRP monoclonal antibodies exhibit superior performance in sandwich and direct ELISA assays.
A.Calibration curve for natural cCRP antigen in the sandwich immunoassay.
B.Canine CRP levels in serum samples from both inflammatory and healthy individuals were measured using antibody pairs in a sandwich immunoassay.
C-D. Sandwich immunoassay was performed to compare PC (phosphocholine) and GMP-CAN-CRP-Ab01 as the capture antibody in the presence (C) and absence (D) of Ca2+.
E.Presence of PC does not affect CRP detection in sandwich immunoassays.
F.Detection of natural cCRP on a direct ELISA platform in the presence of Ca2+ or EDTA using GMP-CAN-CRP-Ab06.
G.The optimal antibody pairs selected based on the immunoassay system.
GeneMedi's anti-cCRP polyclonal antibodies and recombinant cCRP are suitable for use in the sandwich immunoassay system.
GeneMedi supplies polyclonal antibodies that can be used for the development of cCRP immunoassay systems, as well as recombinant antigens suitable for the calibration of cCRP immunoassay reagents, both of which exhibit excellent performance in the sandwich immunoassay system.
Figure 2. GeneMedi’s anti-cCRP polyclonal antibodies and recombinant cCRP show superior performance in sandwich ELISA assays.
A.Calibration curves for recombinant cCRP using mAb-mAb (red) and pAb-mAb (green) antibody pairs in the sandwich immunoassay.
B.Detection results of serum cCRP from normal and systemically inflamed dogs using two antibody pairs in a sandwich immunoassay.
C.Calibration curves for natural and recombinant cCRP in a sandwich immunoassay.
D.Titration curves for recombinant and natural cCRP in a sandwich immunoassay using PC as the capture molecule.
GeneMedi’s anti-SAA monoclonal antibodies demonstrate superior performance in immunoassay.
GeneMedi’s monoclonal antibodies for SAA (Serum Amyloid A) offer high sensitivity for detecting SAA in cat, dog, and horse serum. Due to the high sequence homology among these species, the same antibody pairs can be used to develop versatile sandwich immunoassays. As a result, GeneMedi’s anti-SAA antibodies provide a valuable tool for accurately monitoring and diagnosing inflammatory conditions across multiple species.
Figure 1. GeneMedi’s monoclonal antibodies demonstrate high sensitivity and specificity for detecting SAA in both healthy and inflammatory cat plasma samples using a sandwich immunoassay.
A. Calibration curve for GMP-FEL-Serum-amyloid-A-Ag01 in mixed cat plasma in the sandwich immunoassay. The SAA concentration in mixed cat plasma was 145 μg/ml, and the sample was diluted 208 times prior to testing.
B-C. Dilution curves for recombinant cat SAA antigen and plasma samples using the prototype reagents in the sandwich immunoassay. (B) Healthy cat samples (H1, H2), with SAA concentrations of 0.67 μg/ml and 0.45 μg/ml, respectively. Plasma samples were diluted 45 times before testing. The initial concentration of GMP-FEL-Serum-amyloid-A-Ag01 was 65 ng/ml. (C) Postoperative cat samples (P1, P2), with SAA concentrations of 169 μg/ml and 220 μg/ml, respectively. Plasma samples were diluted 200 times before testing. The initial concentration of GMP-FEL-Serum-amyloid-A-Ag01 was 200 ng/ml.
D. SAA concentrations in healthy and postoperative inflammatory cats. Healthy cat samples were pre-diluted 100-3000 times, while inflammatory cat samples were pre-diluted 9000 times prior to testing.
Figure 2. GeneMedi’s anti-SAA monoclonal antibodies enable sensitive detection of SAA in dog, horse, and cat serum using a sandwich immunoassay.
A-B. Dilution curves of recombinant dog (A) and horse (B) SAA antigens in the sandwich immunoassay. GMP-CAN-Serum-amyloid-A-Ab01 was coated and blocked at 37°C for 1 hour, and incubated with GMP-CAN-Serum-amyloid-A-Ag01 and GMP-EQU-Serum-amyloid-A-Ag01 at 37°C for 1 hour.
C. The recommended antibody pairs.
D-E. Comparison of SAA detection results between diseased and healthy individuals in dogs (D) and horses (E) in the sandwich immunoassay. Healthy serum was pre-diluted 50 times, while diseased serum was pre-diluted 1500 times (horse) or 2500 times (dog), with the dilution buffer containing 1% casein and 0.05% Tween 20.
F-H. Testing results of SAA in cat (F), dog (G), and horse (H) serum samples in the sandwich immunoassay. GMP-FEL-Serum-amyloid-A-Ab10 was blocked for 1 hour (blocking solution containing 2.5% sodium caseinate). Dog serum was pre-diluted 2500 times, while cat and horse serum were pre-diluted 1500 times, using a Tris buffer containing 0.01% CHAPS.
Immunoassay calibration curve for NT-proBNP
These immunoassays have a sensitivity of 22 pg/mL for measuring recombinant NT-proBNP. Figures 1 and 2 display the suggested pairing calibration curves. Conversion of 1NT-proBNP concentration: 1 pmol/L = 1÷10.545 pg/ml Please note that a variety of factors might affect how well an immunoassay test performs. These consist of the labeling procedure, the kind of label coupled to the detection antibody, and the detection platform. Thus, on our customers' immunoassay systems, other NT-proBNP antibody pairs with non-overlapping epitopes could perform better.
Figure 1-2. NT-proBNP immunoassay calibration curve
(left) Calibration curve for optimal paired detection
(right) Calibration curve and canine plasma sample dilution
comparison
Reagent type: two-step sandwich immunofluorescence detection,
streptavidin-coated
microplate
Capture antibody: 200ng/well, conjugated biotin
Capture antibody: 200ng/well, labeled europium chelate
Antigen: Canine recombinant NT-proBNP
(Cat.#GMP-CAN-NT-proBNP-Ag01)
Sample volume: 50μl
Incubation time: 40 minutes at room temperature
Sensitivity detection of NT-proBNP
These immunoassays have a sensitivity of 22 pg/ml 1 for measuring recombinant NT-proBNP. Figures 1 and 2 display the suggested pairing calibration curves. Conversion of 1 NT-proBNP concentration: 1 pmol/L = 1÷10.545 pg/ml Please be aware that a variety of factors might affect how well an immunoassay test performs. These consist of the labeling procedure, the kind of label coupled to the detection antibody, and the detection platform. Thus, on our customers' immunoassay systems, other NT-proBNP antibody pairs with non-overlapping epitopes could perform better.
Figure 3. NT-proBNP concentration in EDTA plasma samples from healthy dogs and dogs with heart disease.
Reagent type: two-step sandwich immunofluorescence detection,
streptavidin-coated
microplate
Capture antibody: GMP-CAN-NT-proBNP-Ab01, 1μg/well
Capture antibody: GMP-CAN-NT-proBNP-Ab02, 200ng/well, labeled
europium
chelate
Calibrator: Canine recombinant NT-proBNP (Cat.#
GMP-CAN-NT-proBNP-Ag01)
Sample volume: 50μl
Incubation time: 40 minutes at room temperature
Stability Test of NT-proBNP
Our antibodies were tested for their ability to detect endogenous canine NT-proBNP during sample storage. EDTA plasma from dogs with heart disease was incubated at two temperatures: +4°C and +20°C. At +4°C, NT-proBNP remains stable for at least 72 hours (95%–105% of initial immunoreactivity, Figure 4A). Simultaneously, at +20°C, about 98% of the initial immunoreactivity is detectable after 24 hours (Figure 4B). Using our recommended antibody pairings, plasma can be stored at +4°C for at least 72 hours with minimal loss of immunoreactivity. However, at room temperature, there is a slight weakening of the signal during the first 24 hours. Note that individual plasma or serum samples may vary.
Figure 4-5. Stability of endogenous canine NT-proBNP in EDTA plasma
(left) Immunoreactivity of NT-proBNP in plasma samples incubated for 24, 48 and 72 hours at +4°C.
(right) Immunoreactivity of NT-proBNP in plasma samples incubated for 4, 8, 24 and 48 hours at +20°C.
Collect protease inhibitor-free EDTA plasma; samples are centrifuged, separated, and stored at -70°C before use. EDTA plasma is stored at +4°C or +20°C with the addition of 0.1% NaN3 to prevent bacterial growth. After incubation, samples were stored at -70°C before measurement. The NT-proBNP concentration in plasma was 9 ng/ml (determined by GMP-CAN-NT-proBNP-Ab01 and GMP-CAN-NT-proBNP-Ab02 immunoassays). Detection using GMP-CAN-NT-proBNP-Ab01 and GMP-CAN-NT-proBNP-Ab05 as capture antibodies and GMP-CAN-NT-proBNP-Ab06 and GMP-CAN-NT-proBNP-Ab02 as detection antibodies respectively The system results are depicted in Figure 3.
GeneMedi's feline cTnI antibodies exhibit superior performance in sandwich immunoassays.
GeneMedi’s GMP-FEL-cTnI-Ab01, GMP-FEL-cTnI-Ab02, and GMP-FEL-cTnI-Ab05 demonstrate superior performance in sandwich ELISA assays. We tested four antibody pairs, and the GMP-FEL-cTnI-Ab01 and GMP-FEL-cTnI-Ab02 pair showed the lowest EC50. Based on these results, we recommend this antibody pair for optimal performance in cTnI detection.
Figure 1. The performance of GeneMedi’s feline cTnI antibodies in sandwich ELISA assays.
A-B. Results of four different antibody pairs in sandwich ELISA assays.
C. Antibody pairs and their EC50 values.
The Top 9 Animal Health Biomarkers: Roles and Importance
This table shows biochemical/diagnostic tests, methods of measurement, the normal reference range, and diseases associated with dogs, cats, and horses. This is useful for veterinarians to help to oversee conditions from inflammation and the infection to heart disease and kidney disease.
Biomarker | Species | Measurement Method | Normal Values | Specimens | Disease Association | Products Information |
---|---|---|---|---|---|---|
SAA (Serum Amyloid A) | Canines, Felines, Equines | Immunoassay | Dogs: <50 μg/mL; Cats: <10 μg/mL; Horses: <20 μg/mL | Blood, Serum | Acute inflammation, infections | Details |
CRP (C-Reactive Protein) | Canines, Felines | Immunoassay | Dogs: <10 mg/L; Cats: Typically low/undetectable | Blood, Serum | Inflammatory diseases, infections | Details |
PCT (Procalcitonin) | Canines, Felines | Immunoassay | Not well-established | Blood, Serum | Bacterial infections, sepsis | Details |
NT-proBNP | Canines, Felines | Immunoassay | Dogs: <900 pg/mL; Cats: <100 pg/mL | Blood, Plasma | Heart failure, cardiac disease | Details |
D-Dimer | Canines, Felines, Equines | Immunoassay | Variable; consult lab ranges | Blood, Plasma | Thrombosis, disseminated intravascular coagulation (DIC) | Details |
cTnI (Cardiac Troponin I) | Canines, Felines, Equines | Immunoassay | Dogs: <0.2 ng/mL; Cats: <0.1 ng/mL; Horses: <0.06 ng/mL | Blood, Serum | Myocardial injury, heart disease | Details |
VD3 (Vitamin D3) | Canines, Felines, Equines | LC-MS/MS, Immunoassay | 30-100 ng/mL (broad range) | Blood, Serum | Bone disorders, metabolic syndrome | Details |
Creatinine | Canines, Felines, Equines | Biochemical assay | Dogs: 0.5-1.6 mg/dL; Cats: 0.8-2.4 mg/dL; Horses: 1.2-2.0 mg/dL | Blood, Serum | Kidney dysfunction, chronic kidney disease (CKD) | Details |
PNLIP / PL (Pancreatic Lipase) | Canines, Felines | Immunoassay (Spec cPL/fPL) | Dogs: <200 μg/L; Cats: <5.3 μg/L | Serum, Plasma | Pancreatitis | Details |
GeneMedi's Recommended Veterinary Diagnostics Products of hot Biomarkers
- Cat / Feline
- Dog / Canine
- Bovines / Cattle
- Equine / Horse
Catalog No. | Products Name | Detected Species | Disease/Condition | Products Type | Products Information |
GMP-FEL-CRP-Ag | Feline CRP (C-Reactive Protein) antigen | Cat/Feline | Inflammatory diseases, infections | protein | Details |
GMP-FEL-CRP-Ab | Anti-Feline CRP (C-Reactive Protein) antibody | Cat/Feline | Inflammatory diseases, infections | antibody(Fc/mFc) | Details |
GMP-FEL-cTnI-Ag | Feline Cardiac troponin I (cTnI) antigen | Cat/Feline | Myocardial injury, heart disease | protein | Details |
GMP-FEL-cTnI-Ab | Anti-Feline Cardiac troponin I (cTnI) antibody | Cat/Feline | Myocardial injury, heart disease | antibody(Fc/mFc) | Details |
GMP-FEL-D-Dimer-Ag | Feline D dimer (D-Dimer) antigen | Cat/Feline | Thrombosis, disseminated intravascular coagulation (DIC) | peptide-(naked/BSA/OVA) | Details |
GMP-FEL-D-Dimer-Ab | Anti-Feline D dimer (D-Dimer) antibody | Cat/Feline | Thrombosis, disseminated intravascular coagulation (DIC) | antibody(Fc/mFc) | Details |
GMP-FEL-NT-proBNP-Ag | Feline NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antigen | Cat/Feline | Heart failure, cardiac disease | peptide-(naked/BSA/OVA) | Details |
GMP-FEL-NT-proBNP-Ab | Anti-Feline NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antibody | Cat/Feline | Heart failure, cardiac disease | antibody(Fc/mFc) | Details |
GMP-FEL-Pancreatic-lipase-Ag | Feline pancreatic lipase antigen | Cat/Feline | pancreatitis | protein | Details |
GMP-FEL-Pancreatic-lipase-Ab | Anti-Feline pancreatic lipase antibody | Cat/Feline | pancreatitis | antibody(Fc/mFc) | Details |
GMP-FEL-PCT-Ag | Feline procalcitonin (PCT) antigen | Cat/Feline | Bacterial infections, sepsis | protein | Details |
GMP-FEL-PCT-Ab | Anti-Feline procalcitonin (PCT) antibody | Cat/Feline | Bacterial infections, sepsis | antibody(Fc/mFc) | Details |
GMP-FEL-Serum-amyloid-A-Ag | Feline SAA (Serum amyloid A) antigen | Cat/Feline | Acute inflammation, infections | protein | Details |
GMP-FEL-Serum-amyloid-A-Ab | Anti-Feline SAA (Serum amyloid A) antibody | Cat/Feline | Acute inflammation, infections | antibody(Fc/mFc) | Details |
Catalog No. | Products Name | Detected Species | Disease/Condition | Products Type | Products Information |
GMP-CAN-CRP-Ag | Canine CRP (C-Reactive Protein) antigen | Dog/Canine | Inflammatory diseases, infections | protein | Details |
GMP-CAN-CRP-Ab | Anti-Canine CRP (C-Reactive Protein) antibody | Dog/Canine | Inflammatory diseases, infections | antibody(Fc/mFc) | Details |
GMP-CAN-cTnI-Ag | Canine Cardiac troponin I (cTnI) antigen | Dog/Canine | Myocardial injury, heart disease | protein | Details |
GMP-CAN-cTnI-Ab | Anti-Canine Cardiac troponin I (cTnI) antibody | Dog/Canine | Myocardial injury, heart disease | antibody(Fc/mFc) | Details |
GMP-CAN-D-Dimer-Ag | Canine D dimer (D-Dimer) antigen | Dog/Canine | Thrombosis, disseminated intravascular coagulation (DIC) | peptide-(naked/BSA/OVA) | Details |
GMP-CAN-D-Dimer-Ab | Anti-Canine D dimer (D-Dimer) antibody | Dog/Canine | Thrombosis, disseminated intravascular coagulation (DIC) | antibody(Fc/mFc) | Details |
GMP-CAN-NT-proBNP-Ag | Canine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antigen | Dog/Canine | Heart failure, cardiac disease | peptide-(naked/BSA/OVA) | Details |
GMP-CAN-NT-proBNP-Ab | Anti-Canine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antibody | Dog/Canine | Heart failure, cardiac disease | antibody(Fc/mFc) | Details |
GMP-CAN-Pancreatic-lipase-Ag | Canine pancreatic lipase antigen | Dog/Canine | Pancreatitis | protein | Details |
GMP-CAN-Pancreatic-lipase-Ab | Anti-Canine pancreatic lipase antibody | Dog/Canine | Pancreatitis | antibody(Fc/mFc) | Details |
GMP-CAN-PCT-Ag | Canine procalcitonin (PCT) antigen | Dog/Canine | Bacterial infections, sepsis | protein | Details |
GMP-CAN-PCT-Ab | Anti-Canine procalcitonin (PCT) antibody | Dog/Canine | Bacterial infections, sepsis | antibody(Fc/mFc) | Details |
GMP-CAN-Serum-amyloid-A-Ag | Canine SAA (Serum amyloid A) antigen | Dog/Canine | Acute inflammation, infections | protein | Details |
GMP-CAN-Serum-amyloid-A-Ab | Anti-Canine SAA (Serum amyloid A) antibody | Dog/Canine | Acute inflammation, infections | antibody(Fc/mFc) | Details |
Catalog No. | Products Name | Detected Species | Disease/Condition | Products Type | Products Information |
GMP-BOV-CRP-Ag | Bovine CRP (C-Reactive Protein) antigen | Bovines/Cattle | inflamation | protein | Details |
GMP-BOV-CRP-Ab | Anti-Bovine CRP (C-Reactive Protein) antibody | Bovines/Cattle | inflamation | antibody(Fc/mFc) | Details |
GMP-BOV-cTnI-Ag | Bovine Cardiac troponin I (cTnI) antigen | Bovines/Cattle | myocardial infarction | protein | Details |
GMP-BOV-cTnI-Ab | Anti-Bovine Cardiac troponin I (cTnI) antibody | Bovines/Cattle | myocardial infarction | antibody(Fc/mFc) | Details |
GMP-BOV-D-Dimer-Ag | Bovine D dimer (D-Dimer) antigen | Bovines/Cattle | Deep vein thrombosis (DVT) | peptide-(naked/BSA/OVA) | Details |
GMP-BOV-D-Dimer-Ab | Anti-Bovine D dimer (D-Dimer) antibody | Bovines/Cattle | Deep vein thrombosis (DVT) | antibody(Fc/mFc) | Details |
GMP-BOV-NT-proBNP-Ag | Bovine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antigen | Bovines/Cattle | Cardiac disease | peptide-(naked/BSA/OVA) | Details |
GMP-BOV-NT-proBNP-Ab | Anti-Bovine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antibody | Bovines/Cattle | Cardiac disease | antibody(Fc/mFc) | Details |
GMP-BOV-pancreatic-lipase-Ag | Bovine pancreatic lipase antigen | Bovines/Cattle | Pancreatitis | protein | Details |
GMP-BOV-pancreatic-lipase-Ab | Anti-Bovine pancreatic lipase antibody | Bovines/Cattle | Pancreatitis | antibody(Fc/mFc) | Details |
GMP-BOV-PCT-Ag | Bovine procalcitonin (PCT) antigen | Bovines/Cattle | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | protein | Details |
GMP-BOV-PCT-Ab | Anti-Bovine procalcitonin (PCT) antibody | Bovines/Cattle | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | antibody(Fc/mFc) | Details |
GMP-BOV-Serum-amyloid-A-Ag | Bovine SAA (Serum amyloid A) antigen | Bovines/Cattle | bovine amyloidosis | protein | Details |
GMP-BOV-Serum-amyloid-A-Ab | Anti-Bovine SAA (Serum amyloid A) antibody | Bovines/Cattle | bovine amyloidosis | antibody(Fc/mFc) | Details |
Catalog No. | Products Name | Detected Species | Disease/Condition | Products Type | Products Information |
GMP-EQU-CRP-Ag | Equine CRP (C-Reactive Protein) antigen | Equine/Horse | inflamation | protein | Details |
GMP-EQU-CRP-Ab | Anti-Equine CRP (C-Reactive Protein) antibody | Equine/Horse | inflamation | antibody(Fc/mFc) | Details |
GMP-EQU-cTnI-Ag | Equine Cardiac troponin I (cTnI) antigen | Equine/Horse | Myocardial injury, heart disease | protein | Details |
GMP-EQU-cTnI-Ab | Anti-Equine Cardiac troponin I (cTnI) antibody | Equine/Horse | Myocardial injury, heart disease | antibody(Fc/mFc) | Details |
GMP-EQU-D-Dimer-Ag | Equine D dimer (D-Dimer) antigen | Equine/Horse | Thrombosis, disseminated intravascular coagulation (DIC) | peptide-(naked/BSA/OVA) | Details |
GMP-EQU-D-Dimer-Ab | Anti-Equine D dimer (D-Dimer) antibody | Equine/Horse | Thrombosis, disseminated intravascular coagulation (DIC) | antibody(Fc/mFc) | Details |
GMP-EQU-NT-proBNP-Ag | Equine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antigen | Equine/Horse | Cardiac disease | peptide-(naked/BSA/OVA) | Details |
GMP-EQU-NT-proBNP-Ab | Anti-Equine NT-proBNP (N-terminal prohormone of brain natriuretic peptide) antibody | Equine/Horse | Cardiac disease | antibody(Fc/mFc) | Details |
GMP-EQU-pancreatic-lipase-Ag | Equine pancreatic lipase antigen | Equine/Horse | Pancreatitis | protein | Details |
GMP-EQU-pancreatic-lipase-Ab | Anti-Equine pancreatic lipase antibody | Equine/Horse | Pancreatitis | antibody(Fc/mFc) | Details |
GMP-EQU-PCT-Ag | Equine procalcitonin (PCT) antigen | Equine/Horse | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | protein | Details |
GMP-EQU-PCT-Ab | Anti-Equine procalcitonin (PCT) antibody | Equine/Horse | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | antibody(Fc/mFc) | Details |
GMP-EQU-Serum-amyloid-A-Ag | Equine SAA (Serum amyloid A) antigen | Equine/Horse | Acute inflammation, infections | protein | Details |
GMP-EQU-Serum-amyloid-A-Ab | Anti-Equine SAA (Serum amyloid A) antibody | Equine/Horse | Acute inflammation, infections | antibody(Fc/mFc) | Details |
*Note:
1. The bioactivity of the antigen, as demonstrated through its binding capabilities and role as an
immunogen
in sandwich ELISA, lateral-flow tests, and other immunoassays, serves as a control material in
disease-related
assessments.
2. The paired antibody demonstrates bioactivity by binding to its recombinant antigen, validated in
ELISA as
both a capture and detection antibody for disease testing.